CavatermTM vs TCRE in Women With DUB

Inclusion Criteria: * Willingness and adequate mental capacity to sign written, informed consent * Willingness to adhere to study plan regarding control visits and recording of PBLAC * \> 30 years old * Pre-menopausal as determined by FSH ≤30 * Agree not to use hormonal contraception or any other intervention for bleeding during study * Suitable for local and/or general anesthesia * A minimum PBLAC score of ≥ 150 for three months prior to study enrollment; OR PBLAC score 150 for one month for women who 1) had at least 3 (documented) prior months of failed medical therapy; 2) had a contraindication to medical therapy; or 3) refused medical therapy * Uterine cavity sound measurement ≥ 4 cm and ≤ 10 cm. Exclusion Criteria: * Presence of bacteriaemia, sepsis, or other active systemic infection * Active pelvic inflammatory disease * Clotting defects or bleeding disorders * Unwillingness to use a non-hormonal birth control post-ablation * Desire for future fertility * Abnormal cavity as confirmed by hysteroscopy, transvaginal ultrasound or HSG e.g. large fibroids, septum etc. Small submucosal fibroids defined as \< 2 cm are in this context not considered abnormal. * Any condition leading to possible uterine wall weakness with total wall thickness \< 15 mm e.g. at c.section, postmyomectomy scars etc. In case of uniform uterine wall the wall thickness at the fundus should be measured. * Premalignant or malignant uterine condition within the last five years as confirmed by histolog…